1. In the section of 'Treatment groups', it was mentioned that valproic acid was injected at 48, 60 and 72 hours after ischemia. However, rats in baicalin group got administered immediately after ischemia once daily for 3 weeks. The statistical testing results showed that baicalin had a lower neurological score at day 14 and 21 compared with the VPA group. I'm wondering if the different administration methods between these two groups contribute to the significant testing results as rats in VPA group received nothing after 72 hours. Please clarify. In addition, it is not clear on the administration method for control group, eg, injection frequency.
2. In the section of 'Statistical analysis' and 'Results', it is actually the mean neurological score and mean infarct volume are compared among the three treatment groups. Suggest using 'Mean Neurological score' and 'Mean Infarct volume' to label the y-axis in the two figures and also clearly mention it in the content.
